

5 Oct 2026 · 43m · 22 chapters

Fast Money episode (10/5/26) focuses on: (1) why the U.S. dollar is surging to 1+ year highs and what that means for rates and equities; (2) whether the biotech/pharma trade can keep running after a pullback; (3) sector trades including energy despite falling crude; (4) Chipotle’s continued weakness; (5) international/global themes like Brazil; and (6) prediction-market odds.
John Flavin, founder/CEO of Portal Innovations (biotech/venture investing; emphasizes pharma M&A and late-stage assets, including China-sourced deals). JP Coviello, head of portfolio strategy at CitiWealth (macro/portfolio positioning; underweight duration; favors tech, cybersecurity, gold/commodities).
Dollar strength driven by Fed/inflation focus, strong U.S. data, and Europe/Japan dynamics; higher rates and a stronger dollar are a headwind for equities but tech is acting as “flight to quality.” Pharma: M&A around $135B in 2026, mostly $1–$10B bolt-ons; big pharma wants phase 2/3 proof. Examples: AbbVie buying Cerevel; J&J acquiring Intercellular; AbbVie’s Jubmo approval; SpaceX test-flight optimism; Morgan Stanley upgrade of Wells Fargo; Morgan Stanley upgrade cited for NIM/stability.
Written by AI. May contain mistakes.
Discussion on the dollar's rise, market impacts, and macroeconomic factors.
“And we start off with the recent big gains in the greenback, the dollar index hitting its highest level since April of last year.”
Exploration of market behaviors, treasury yields, and investment strategies.
“Actually, Stephen Tower is watching right now.”
Focus on tech stocks and their performance in the current market environment.
“That's the 60 portfolio, 60, 40 portfolio.”
Delving into the earnings outlook for tech stocks and market volatility.
“And you're like, I remember when you guys first moved in.”
Discussion on future market strategies and the potential for diversification.
“And you also pointed out that the 2-10 spread is at a level that we haven't seen in a long time.”
Discussion about valuation compression in markets and its implications.
“Actually, markets somewhat getting cheaper around the edges.”
Exploring strategies for diversifying portfolios amidst changing market conditions.
“Valuation compression has been happening since the start of the year.”
Analyzing current bond yields and their implications for investors.
“But how about just what's going on with with treasure yields?”
Discussing expectations for growth, inflation, and their impact on investments.
“Expecting 27 percent growth this quarter after double digit for the past four, I think it's actually going to depend on the rate of change of earnings growth more so than a yield level.”
Previewing the upcoming discussion on energy stocks amidst market changes.
“And how do you trade the names right now?”
Examining the performance of energy stocks despite fluctuating oil prices.
“When you use Angie for your home projects, you know all your jobs will be done well.”
Analyzing the recent struggles of Chipotle and its market valuation challenges.
“when we've had oil prices do what they do, but not just because oil prices.”
Discussion on the cyclical nature of fast casual dining and investment implications.
“You know, for a longer term investor, probably not still.”
A discussion on the performance of fast casual restaurants and market trends.
“Although with a$40 billion market cap, you wonder what the takeout price is going to be.”
Preview of the upcoming discussion on the pharmaceutical sector.
John Flavin discusses the current state and future outlook for pharma stocks.
“Welcome back to Fast Money Stocks, starting the week in the green with the Nasdaq jumping a percent and the Nasdaq 100 up nearly nine-tenths of a percent, both setting record closes.”
Exploration of longevity investments and their potential in the market.
“You feel even worse about Novo now, right?”
Discussion on Brazil's political situation and its implications for investments.
“Welcome back to Fast Money, The Brazil ETF hitting its highest level since February of 2020 after jumping more than 12 percent today.”
An overview of prediction markets and unusual betting contracts.
“But how would you get Brazil in your clam?”
Explore the growing trends in prediction markets and their implications.
“economic risks to one literally out-of-this-world contract.”
Discuss the intriguing market odds regarding the confirmation of alien life.
“But at one point, 57 percent probability that the United States government would confirm the existence of aliens by January 20th, 2029.”
Hear the hosts' final trade recommendations before closing the show.
“I mean, the Health and Human Services secretary counts as a cabinet secretary.”

Get the gist, explore an idea or ask about something said.
On CNBC's "Fast Money", what are the key points of this episode?
Automatic transcript. May contain errors.
0:02At Janice Henderson Investors, we believe working together is the way to work better. Like combining your portfolio plans and our in-depth strategy, your valued assets and our valuable insights, your vision and our mission. Working in harmony to seek the right investment opportunities. Janice Henderson Investors. Investing in a brighter future together. If you're a small business, the right hire can be make or break. Indeed Sponsored Jobs gets you quality candidates when you need them most. Join the 3.3 million employers worldwide that use Indeed to connect with quality talent that fits their needs.
0:44Listeners of this show will get a$75 sponsored job credit to help get your job the premium status it deserves at Indeed.com slash podcast. That's Indeed.com slash podcast. Terms and conditions apply. Hiring now? Then this is a job for Indeed-sponsored jobs.
1:02Tim Seymour: Live from the NASDAQ Market Sight, right here in Times Square on the night when the tech-heavy index set a record close. This is Fast Money. Here's what's on tap tonight. Digging in on the dollar, the greenback at more than one-year highs, what is driving the gains, what's it mean for the rest of the markets? We'll debate that. And a biotech boom, the group far outperforming the broader markets this year. Can the gains keep coming? And what names could be ripe for a takeover bid. Plus, oil stocks spike even as the commodity price comes under pressure. Investors take a bite out of Chipotle shares.
1:30Tim Seymour: In liftoff for SpaceX, Elon Musk's rocket company posting its highest close since mid-June, returning its CEO to trillionaire status, the latest headlines behind that move. I'm Melissa Lee, come to you live from Studio B at the NASDAQ. On the desk tonight, Tim Seymour, Karen Feinerman, Guy Dami, and Julie Beal. And we start off with the recent big gains in the greenback, the dollar index hitting its highest level since April of last year. Concerns over France's burgeoning budget deficit sent the euro sliding, that currency riding a four-week losing streak and taking the CAC 40 down with it. But here at home, it was green across the board.
2:04Tim Seymour: Nasdaq leading major indices up a percent. It and the Nasdaq 100 both setting intraday and closing records. Even as long-term Treasury yields continued their trek higher, the 10-year hitting a new 24-year high. And the spread between it and the two-year at its widest since August. So can the dollar keep up its momentum? And what does this mean for the domestic markets and, of course, for rates? Tim, what do you say? Well, the dollar often is a central bank differential kind of a read. It's obviously a lot of macro involved. We had a very strong ISM services, which shows that the services part of the economy is clicking along.
2:37There is some sense, though, that the Warsh Fed is very focused on inflation. And whether we go in October or December or once or three times, I think that is a lot to do with the rally in the dollar, because I think the dollar was meandering for almost 12 months and now has broken higher over the last, I would say, two weeks. I think some of that's a function of Europe. And remember, the Dixie or the dollar basket is about 60 percent euro. The rest is heavy yen and then a smattering of the rest of the world. And I think if you look at what's going on in Bank of Japan right now, again, all this tells us the dollar could go higher.
3:15And I think as we led the show here, all of that has some impact on markets. It's first higher rates, now higher dollar. At some point, that bites equities.
3:24Dan Nathan: You a fan of Aerosmith, by any chance?
3:27Tim Seymour: I can't say that. Do they watch the show? They do. Actually, Stephen Tower is watching right now. I enjoy occasional TV.
3:33Dan Nathan: They did a cover of Train Kept a Rolling. And Tim's not a big Smitty fan. But that's what Train Kept a Rolling all night long. And that's what's happening here in the market. It just continues to go on its merry way until something stops it. But in terms of the dollar, Treasury cannot be happy about this. Because when you have a$40 trillion debt problem, the last thing you want is your currency to strengthen what you owe people to be worth more. And they've been pretty open about their want for the dollar to actually not be as strong as it is. And with rates going higher, it's a double whammy for them.
4:01Dan Nathan: So at some point, something will get done. But a higher dollar historically has created a bit of a headwind for equity markets. So I'm wondering about the higher dollar. So a bunch of things going on sort of at cross currents. If what's going on in France creates a flight to quality, right? So would that be a flight to the dollar and to U.S. treasuries? But the treasury part doesn't seem to be happening unless it's all very much the front end, which may be the case, but not if you look at what's happened, like the CDS on France 10-year paper, right? That's had a gigantic move. If that's repatriation of dollars to buy bonds, or not maybe repatriation, somebody leaving somewhere else.
4:44So maybe was the move in bonds even more pronounced than it would have been otherwise? Because of this? Yes, because there is a bid from around the world. I don't know. That's a question.
4:57Tim Seymour: I was thinking that there didn't seem to be any bid and that the bid was going to the dollar as opposed to treasury. I don't know. What was your take on? Well, I think this political volatility in France, certainly the very fragmented National Assembly is something that I think is we've been weighing this for a couple of weeks. Steve Leisman, we talked about how, you know, oat yields, as they're called over there, guy, you know, not gilts, not oats. No, no, I know this. Yes. And so the 10 year Treasury, the 10 year French Treasury is something that's come under a lot of pressure. It's just interesting because it used to be Southern Europe and now it's Northern Europe.
5:33I think this is a combination of what's going on at home. I think this is a combination of energy prices and the impact that they have disproportionately on Europe. I think it's a case where we're going to continue to be somewhat sideways here. And I do think it adds to a bid, a flight to quality in certain parts of U.S. assets. I'm not sure anyone anywhere wants to own the long end of the curve. And that's for reasons that are both budget deficit to GDP, AI issuance, inflation, and really just general concern. Duration is not your friend right now. And back to a conversation we had last week.
6:06It's kind of interesting, though, that asset allocation is working here. In other words, equities are rallying. Bonds are selling off. That's the 60 portfolio, 60, 40 portfolio. And it's kind of working after it wasn't working for a long time.
6:18Tim Seymour: But the 60 part is really 40 percent tech. I mean, or the 40. Right. The biggest technology stocks, Julie Beal. I mean, that that is the perceived defensive area of the market in light of a sticky 5.3 percent. that may be going higher at this point. Would you agree with that? No, I absolutely agree. I think that we lose sight of just how much concentration there is in the market. And in ye olden times, these mega cap technology companies were not a factor in the debt markets. And now we're seeing a real crowding out where they are viewed as very high quality credits to lend to. And suddenly, we've gone from, we have not enough good assets to invest in to now we have too many assets to invest in.
6:59And I think that that makes the French market look really difficult. But I think it's also a lesson for us, you know, in the U.S. in terms of as we get more and more polarity and we don't do the hard work in terms of our entitlements, we end up with these more fragile systems where the uncertainty path gets really wide because we're talking about two very different polarities in terms of how to solve the problem.
7:23Tim Seymour: Is the flight to safety or should the flight to safety be to technology still? I mean, if the flight to safety has to have some equity component, right, then I think it should, even though, you know, it's concentrated. But also it is the best balance sheets, the best businesses. So and the highest growth. So, yeah, that's how I'm positioned. It's not that comfortable, but that's where I am. By the way, when Julie brought Ye Olde, and my guess is you're the kind of a guy when you walk down a main street somewhere and some place is like Ye Olde Ice Cream Shoppy. I go right in. You hate that. Because it's better.
8:04Tim Seymour: Ye Olde. And you're like, I remember when you guys first moved in. Customer number one. I used to go with Paul Revere.
8:14Dan Nathan: There are a lot of issuances coming. I mean, I think people think there's going to be this flight to quality in the bond market at some point. Karen mentioned it. It's not happening. And as issuance continue to come in, it just creates more and more supply, less and less demand, which means rates go higher and higher, which is a problem. Now, right now, in my opinion, the gold market likes none of this. Higher yields and a higher dollar is not good. At some point, though, I think the markets can wake up and say, wait a second, what is this deterioration on the back of? And maybe we should be in gold after all.
8:43Dan Nathan: And that's coming to a theater near you really soon.
8:46Tim Seymour: I mean, it'll be interesting if we do see a higher 10-year yield, then it does put a lot more pressure in terms of funding that AI build. I mean, why take credit risk? How much more will you demand to be paid to take on that credit risk when you can get a 10-year yield at 5.4%, whatever it may be at the end of the day? Well, why is it? I mean, it's sort of this cycle again of huge growth. Huge growth is what, you know, we saw that ISM number one could say, all right, there's really good growth. There's also inflation. If growth is the reason, then I think it's OK. You still want to be there. I guess it depends on the time frame now.
9:25Tim Seymour: The time frame for how long you think... Yeah. Oh, yeah, what your time frame is for how long you want to hold the security? Yeah. Yeah. Well, we do a show every day. Called Fast Money. Yeah, exactly. That's true. I think it's really... It's as easy as looking at what the NASDAQ has done. Forget semiconductors, because in some sense... But at least let's broaden it out to the NASDAQ and say that the triple Qs, since September 15th, excuse me, have outperformed the S &P by almost 6%. And that to me, and by the way, September 15th is really, since that point, is when we've seen 10-year yields go up 35 to 40 basis points.
9:58So you tell me, the flight to quality is absolutely to tech. And even though Meta's balance sheet is very different than it was, and these are not necessarily net cash companies, I still think people feel very, very comfortable with those companies.
10:13Tim Seymour: And by the way, this is the exact environment NVIDIA looks good in. I mean, NVIDIA, which hit a new high in today's session. But at 17 times forward, I mean, it looks like a no-brainer if you're thinking about all these different factors.
10:26Dan Nathan: We are fortunate to have you hosting this show. But you also host the 6 to 9 show from time. That, of course, would be the Squawk Box. And I'm sure you watch. She was on all day today. All day. But Gene Munster, fan of this show, was on this morning with Becky and Joe and Andrew talking about exactly what you just said. He is convinced, by the way, that this is really early in this entirety of this whole thing. And the growth trajectory, although mind-boggling, actually is going to continue. So you should listen to Gene if you want to reinforce your bullish thesis.
10:55Tim Seymour: Yeah. And Julie, ditto for a lot of the MAG-7 for that matter when it comes to valuation. Yeah, I think that the problem is, and I think the recognition of these low valuations, or apparently low valuations, is I think people have real questions about the earnings outlook. So, you know, it is really easy to say NVIDIA at 17 times looks amazing. But if there is any deterioration in that demand, you're going to feel it pretty profoundly ripple through. And that E is going to look very, very different. So I think that is why they trade the way that they do. People are still concerned that, you know, there's still a lot of concentration in terms of the MAG7 earnings.
11:31And even the earnings relative to where they revalue their private ownership in Anthropic and OpenAI, it's still sizable. And so I think people don't feel like the earnings quality is as high as it used to be. And as we talk about the MAG-7, and then we've also just talked about what outperformed it. I mean, financials had a nice day. And you also pointed out that the 2-10 spread is at a level that we haven't seen in a long time. And by their very nature, banks tend to be borrowing short, lending long. And the net interest margin dynamic is something that only should be getting better, except for the fact that I think for a good part of this move higher in rates, we weren't really sure where banks were.
12:08in addition to the things that banks were saying about their particular business that weren't going to be as robust as they had been. I say all this to say there's a lot of different places to be looking at what's going on with rates and saying, hey, this could be something we should be very worried about. It also could be a little bit more of an opportunity. We have not seen a credit cycle yet. And at some point, I think there will be an impact. But I think banks should be trading better than they do. And today was a day where it felt like the rest of the market wanted to catch up to that tech trade.
12:38Tim Seymour: Yeah, to that point, I mean, Morgan Stanley just today upgrading Wells Fargo on stability and net interest margin. So they're highlighting that point specifically. I always wonder now, does then Wells Fargo feel like, all right, well, now I need to be anything. You know, just that's how it rolls. It doesn't work like that, you know. I know, I know. I like I agree with Tim. I like the bank sector. I do like the setup going in. We're only, you know, Tuesday of next week. We'll see JP Morgan, and I like the space. For more on where markets go from here, let's bring in JP Coviello, head of portfolio strategy at CitiWealth.
13:11Tim Seymour: JP, great to have you with us.
13:13Dan Nathan: Great to be back. Thank you.
13:14Tim Seymour: So is this playbook into the end of the year going to be just hideout in technology? And I say hideout in quotes because it's not necessarily a hideout place for a lot of people, but relatively speaking, it is.
13:25Dan Nathan: I get it. I mean, the flight to safety questions, is it tech? Really, for us, the fundamentals continue to show that tech is the place to be. We're seeing higher earnings revisions come through in the tech sector. We're also seeing it in banks, actually, since the Q2 reporting season. We've seen earnings revisions move 2 % higher since Q2 reported, and usually they trend lower by 2 % during this time period historically. So for us, yes, following the fundamentals, we are seeing tech as the place to be right now. So actually, valuation compression that you speak of, which counterintuitive, somewhat counterintuitive, market goes up.
14:03Dan Nathan: Actually, markets somewhat getting cheaper around the edges. Thoughts on that dynamic? Great point. I was going to bring it up, but glad you did. Thank you so much. I should go home right now. I win.
14:13Tim Seymour: See you.
14:14Dan Nathan: Exactly. Valuation compression has been happening since the start of the year. We've had an over 100 basis point move in rates, and let's break it apart. Most of that move has come from real yields. So growth and productivity oriented, not inflation break evens. So good reasons for yields moving higher. That multiple compression has brought us down to about 19 times at an index level, which over a five year look back looks pretty good to us. And so we actually added to U.S. large caps last week, a little bit to Japan and a little bit more to cybersecurity, which spoke about last time. Is there some point where you just say, all right, that's too we're too tech heavy.
14:52What's the next place you would diversify into?
14:54Dan Nathan: It's a great question. And we've been thinking about we're in a different regime than we've seen historically. So upstream natural resources, commodities for us are a big piece of our diversification move, especially when duration is not working. We have added to gold over the past year and a half to replace some of our duration in portfolios. Obviously, tough sledding to start this year, given the move in real yields. But should that slow over time, we still think that remains a core ballast in a multi-asset class portfolio, in addition to the broader commodity piece, given what's been going on in growth and inflation.
15:27So, JP, and with Guy and Karen asking such great questions, I realize the bar is high. But how about just what's going on with with treasure yields? And how about an opportunity? Aren't bonds oversold? I mean, if you're buying bonds today, you're not dealing with the last 50 basis points. I mean, I would think on some sense, you know, again, this is portfolio strategy. you, you're licking your chops. Is that a great question?
15:49Dan Nathan: That is mediocre. When you have to ask, it's like, is that a funny joke? I know. Who do people tell me I look like? What's my nickname? Fantastic question. Let's put it that way. Yes. Yes. We've done the work here. And for us, we've been heavily underweight duration all year. Just the view on stronger growth, the Fed had cut into an expansion last year. Really, we did not feel good owning it with reasons you mentioned before. Fiscal deficits expanding around the world. I haven't seen one country say we're going to reduce our fiscal deficit going forward. So for us, is it an opportunity? For the right investor, it's the right opportunity because your starting yield determines much of your return.
16:30Dan Nathan: However, for us, it's more important to think about the cycle and when you want to own it in a multi-asset class portfolio more in an overweight perspective. And that's typically when the Fed starts cutting rates and the cycle turns. And in our view, we're just not even close to that for some of the reasons you all detailed before I got on.
16:47Tim Seymour: So underlying that answer, is there a belief that yields go above 5.3 percent?
16:53Dan Nathan: There is. Yes. Given the momentum we're seeing in growth, you mentioned the PMIs earlier. We had services, PMIs, services ISM today, right? Highest prices paid number in four years. Philly Fed prices received estimates highest since 1981. So there's some work to do here. In our view, the growth and inflation side remain elevated relative to history. And in our view, yields likely do move higher from here, yes.
17:22Tim Seymour: Is there a level of yield at which you think the tech trade doesn't work as well?
17:26Dan Nathan: I think that would actually depend upon the earnings growth for them, because the earnings growth has been so spectacular. Expecting 27 percent growth this quarter after double digit for the past four, I think it's actually going to depend on the rate of change of earnings growth more so than a yield level.
17:44Tim Seymour: Okay. JP, good to see you.
17:45Dan Nathan: Great to see you. Thank you for having me.
17:47Tim Seymour: You didn't comment on my question, I guess. It was okay.
17:55Tim Seymour: Do you think that there's a place in portfolios for treasuries? I do. And again, but he was right. I'm going to pat JP on the back. I don't think he's here technically anymore on the show, but I do think the point is your time horizon. And there's a chance to wait for that period where the Fed is cutting rates or not even. And again, you want to own it for its yield component. But there is a total return component of buying some treasuries right now that I think will be interesting for the next six months. Yeah. Julie? Yeah, I agree. I think that there is a certain need to create a little bit of safety in a balanced portfolio.
18:31And at these yields with so little risk, to me, it gives its own kind of diversification, right? Because if there is softness, I think you will see a lot of improvement in the pricing of these yields for, you know, probably the near term, at least.
18:46Dan Nathan: That's a handsome man. Brad Cooper should play him in the movie. Bradley Cooper. Yeah. Georgetown grad, by the way, not JP. Listen, he makes compelling points. The point about the market actually being cheaper now. I mean, you know, I saw that in the notes and I jumped on it because factually it's true. The question is, again, the right question is, is it going up for the right reasons or the wrong reasons? I continue to think wrong reasons.
19:09Tim Seymour: Coming up, crude oil down, but energy stocks up. What's behind the disconnect? And how do you trade the names right now? And speaking of rough runs, Chipotle shares riding a burrito bummer over the last month. Where the traders see this one heading next. Don't go anywhere. Fast Money is back in two.
19:27Dan Nathan: This is Fast Money with Melissa Lee, right here on CNBC.
19:54Dan Nathan: What comes next? And it lives inside every MDX, ADX, and Integra. That's precision-crafted performance. That's Acura. Comcast Business is now offering advanced big business cybersecurity for small businesses with an AI-powered firewall built right into your network connection. Switch to Comcast Business and get started for just$50 a month for one year on a qualifying internet package with one month of Security Edge preferred on us. Plus, for a limited time, ask about a$500 prepaid card. Call today. Limited time offer. Restrictions apply. New customers only. Requires 300 megabits per second internet.
20:24Security Edge. Security Edge preferred and wireless connect. One year agreement, paperless billing and automatic payments required. Equipment, taxes and fees extra after promo regular supply. Hi, I'm Angie Hicks, co-founder of Angie. When you use Angie for your home projects, you know all your jobs will be done well. Roof repair? Done well. Kitchen sink install? Done well. Deck upgrades? Done well. Electrical upgrade? Done well. Angie's been connecting homeowners with skilled pros for nearly 30 years. so we know the difference between done and done well. Angie, the one you trust to find the ones you trust.
20:58Tim Seymour: Find a pro for your project at Angie.com. Welcome back to Fast Money. Crude oil pulling back for a second straight day. WTI down nearly 2 % to settle below$90 a barrel. Energy stocks, though, catching a bid with all but two components in the XLE, finishing in the green Valero, SLB, Halliburton, and Marathon Petroleum, leading the sector higher. Karen, this is in your bid. bidet. I don't know if it's a bidet. I think it might have been last year. I think it's last year. I should have.
21:28Dan Nathan: Pull up a bidet and see what it is. I mean, you'll crack staff at EC. Can I just point out that the fact that you don't even know that if it's in there or not means you're not playing the game by the rules. That makes an excellent point. Okay, fine. Whatever. Look, as the guy who's in like ninth place, I'm obviously bitter and I'm lashing out. I mean, I know what that's going on. I do. I think we all agree that the energy trade has been a really good one. I don't know if it finished the day, but the OIH, every component was up. And, you know, oil was a little bit lower. And yet there was just strength across the board.
22:05So I think we've talked a lot about the trade working. Obviously, we have this, you know, the very unusual situation. They ran situation oil moving a lot. Even without that, though, I think it's under owned. Maybe not as much, but still under-owned. I'm still staying long.
22:23Dan Nathan: OIH was$440 in the beginning of September. It's now the beginning of October. It's come off significantly, and maybe justifiably so. I don't think so. But I think you're catching a break here in these services names. And Valero, Marathon, PSX, they continue to trade like they have earnings power like they've never had, which, by the way, they do.
22:42Tim Seymour: By the way, for those playing at home, Carbed was Karen's previous. Yes, because E was for energy. XLE, energy. It was for energy. Yeah. Why is that so difficult, people? Come on. It's not, and maybe I'm the one that just doesn't understand. But what I don't understand is how the XLE can be up less than 20 % since the beginning of the war when we've had oil prices do what they do, but not just because oil prices. I get that oil companies don't like spikes in oil prices. When you're investing in commodity producers, sometimes those spikes aren't grounds for going out and grabbing. In fact, that volatility is a problem, except for the fact that energy infrastructure, the build out, the world of inventories, it just tells me that there's a bigger opportunity.
23:26If this was options action, I would even say call spreads. I would say it's an opportunity because, by the way, buying upside volatility in energy names isn't that expensive. Therefore, selling it's not that great. But I do think there's a chance to be buying upside in energy names that the market is not pricing in. Yeah.
23:42Tim Seymour: Jillian, it's also, I mean, it has been considered a hedge to what's going on in the war. I think it does give you some kind of stability in your portfolio. But quite honestly, it's not like the stocks are behaving poorly in the face of the war. It really hasn't mattered. If you had just ignored the headlines, you probably would have been fine, but you might have missed out on the rally on some of these oil names. And it's true, like the earnings power, when you compare last year versus this year, it's totally a different ball of game. You have companies that weren't even earning positive returns, now generating positive returns.
24:15And so I think that makes people feel comfortable. Can we own this sector a little bit like they have been with semiconductors? You know, for a longer term investor, probably not still. But I think there's opportunity in the near term to add like a little stabilizer to your portfolio with this.
24:30Tim Seymour: There's a lot more fast money to come. Here's what's coming up next.
24:35Dan Nathan: Chipotle shares getting crunched. Shares of the restaurant chain hitting near four-month lows. Can the stock stage a turnaround, or is this burrito breakdown going to continue? Plus, the outlook for the healthcare trade. From Chinese drug makers gaining ground to a potential boom in the IPO market, where one venture capitalist sees the sector heading next. You're watching Fast Money, live from the NASDAQ market site in Times Square. We're back right after this.
25:31Dan Nathan: ADX and Integra. That's precision crafted performance. That's Acura. Comcast Business is now offering advanced big business cybersecurity for small businesses with an AI-powered firewall built right into your network connection. Switch to Comcast Business and get started for just$50 a month for one year on a qualifying internet package with one month of Security Edge preferred on us. Plus for a limited time, ask about a$500 prepaid card. Call today. Limited time offer. Restrictions apply. New customers only. Requires 300 megabits per second internet. Security Edge. Security Edge preferred and wireless connect.
26:00One-year agreement, paperless billing, and automatic payments required. Equipment, taxes, and fees extra. After promo, regular rates apply. Hi, I'm Angie Hicks, co-founder of Angie. And one thing I've learned is that you buy a house, but you make it a home. Because with every fix, update, and renovation, it becomes a little more your own. So you need all your jobs done well. For nearly 30 years, Angie has helped millions of homeowners hire skilled pros for the projects that matter. From plumbing to electrical, roof repair to deck upgrades. So leave it to the pros who will get your jobs done well.
26:30Angie, the one you trust to find the ones you trust. Find a pro for your project at Angie.com.
26:38Tim Seymour: Welcome back to Fast Money. More indigestion for Chipotle shareholders. The stock down another 4-plus percent today, closing at its lowest since late June. Shares have lost a fifth of their value since the start of September. Other restaurant stocks have also been under pressure. Wendy's down nearly 25 percent in the last month. But this is a burrito bummer, if you will. Guy? Oh, I'm sorry. I don't know. Well, it's it's anybody's bummer. The problem is after this kind of a move and after what's been a sustained move over almost two years, I don't think the stock's cheap. I don't think it at 27 times forward in the environment we're in, especially when there's a lot more pressure on their core business that I want to be going out and chasing this thing.
27:20So I love the product, although, again, I'm going to rail against 73rd and Amsterdam. They're open till 11, yet they don't have half the ingredients by nine o 'clock p.m. So you should just close up. I'm telling you that. I'm doing a favor to the company because I bet they're doing this in other stores as well.
27:35Dan Nathan: He actually, Tim, makes an excellent point. At a certain hour of the night, if you're looking to get dinner, you're not going to get a lot of the ingredients that you want. Which is part, I think, that might be part of the problem, believe it or not. I mean, they have a growth. Listen, when the growth trajectory was what it was a few years ago, nobody cared about valuation. When it's on the other side of growth, now everybody cares about valuation. And even with the move now, it's not a cheap stock, unfortunately. So there was some M &A chatter, I think, at the end of September that got the stock higher.
28:02Dan Nathan: You might hear more about that. Although with a$40 billion market cap, you wonder what the takeout price is going to be. So I think you've got to stay away for a while. I sort of like Kava, but I can't buy it. It's just way too expensive. And also, I mean, all of these have very high multiples. And, right, we have rates going higher. The multiples should be less high. And yet they're still stratospheric. Not even close for me.
28:27Tim Seymour: Yeah. I mean, it's interesting, even within this sort of fast casual space, the higher sort of price point players are not doing considerably better than the I mean, they're doing better. Right. With the K shaped economy versus the lower K, if you take a look at McDonald's or Chipotle, I mean, neither are doing well. No. And again, Chipotle is not a growth play anymore. So that was a time to pay for the multiple. We've had a lot of conversation about McDonald's and I have been slowly picking at that one. I'm fine owning this one, and I don't think that there's something broken there. I do think it's a cyclical story.
29:02Tim Seymour: We haven't done Would You Rather in a long time. Oh, let's do it. Since we're having fun, what would your Chipotle order be? I don't go to Chipotle. Something with chicken. That's not fun. Something with chicken in a bowl. How's that? Chicken in a bowl. That could bring them back. Call up the Melissa Litt. I'll tell you what. Chicken in a bowl. Chicken in a bowl. They didn't get there late at night. Do they have chicken in a bowl available? No. Nothing in a bowl. There's the three ingredients you don't want that are left, and they don't look that good. I'm sorry. And, like, I hate to bring it up again, but you just started it.
29:30Tim Seymour: Anyway. Sorry. Back to the would-you-rather that I would have asked three minutes ago, Julie, Chipotle or McDonald's? Oh, probably McDonald's. I think there's more stability under this business. I have more confidence that they can manage through cost than Chipotle. I think that's a real big challenge for them. Also, who's getting dinner at 11? Yeah, that's a problem, Julie. That's fair. That's totally fair, and I don't sleep well because of it, too. That's another show. But you didn't even mention the pint of Ben and Jerry's that you'll have after. That's another issue, but it just gets going later.
30:04Tim Seymour: All right, coming up, the prognosis for pharma stocks after a recent pullback in the group what our next guest sees in store for the drug makers and the potential reopening in the biotech IPO pipeline. Fast Money's back in two.
30:18Dan Nathan: Missed a moment of fast? Catch us anytime on the go. Follow the Fast Money Podcast. We're back right after this.
30:28Tim Seymour: Welcome back to Fast Money Stocks, starting the week in the green with the Nasdaq jumping a percent and the Nasdaq 100 up nearly nine-tenths of a percent, both setting record closes. The S &P meantime, half a percent from a record of its own, while the Dow added 90 points. NVIDIA also setting a record close. It's first since May. The chip giant's market cap now$900 billion more than Apple's. That is a gap bigger than all but 12 members of the S &P 500. Shares of SpaceX jumping nearly 8 % today as Wall Street gets bulled up on the name ahead of test flights. Morgan Stanley's Adam Jonas saying SpaceX is one of the cheaper ways to play the strong optionality of the space and intelligence economy.
31:05Tim Seymour: The next test flight of the company's new Starship rocket expected later this month or in early November. Today's move in both SpaceX and Tesla helping push Elon Musk back into trillionaire status. Meantime, pharma stocks have slid in the past month after a slew of clinical trial setbacks and as investors rotate out of the sector for a check on what's next for the group. We are joined by John Flavin, founder and CEO of Portal Innovations. John, great to have you in person here. Thank you. There had been this theme that you invest in biotech because they are all targets to some degree. Big cap pharma, they have to do something about their pipelines.
31:40Tim Seymour: Does that still hold true in your view? Definitely. And I think the data speaks for itself. If you look at the results over the course of 2026, it's been really a torrent flow of activity in M &A. Pharma, you know, racking up around$135 billion in deals, mainly bolt-on deals,$1 to$10 billion deals, not the big mega merges that you've seen in the past. That's good for biotech because biotech is usually going to be priced in that$1 to$10 billion category. And that's fuel for these pharma companies, especially late-stage clinical assets. that are going to fuel their pipeline as they go off patent with some of their key assets.
32:15Tim Seymour: Yeah, I mean, the big cap pharma companies want to see proof, right? They're not buying flyers anymore. They're buying phase two, late phase two, phase three assets at this point. Exactly. And that's kind of what you're seeing in the venture markets as well. So private equity, early stage investing are all happening in really late stage opportunities. The product's got to be in the clinic. Oftentimes now, more often than not, you're seeing some of those assets coming from China, which is very interesting. If you look at the activity that we've seen this year with China biotech on the rise.
32:45Dan Nathan: John, we talk about GLP-1's obesity. I mean, that's what we talk about seemingly when we bring up biotech and pharma. But central nervous system pain, like there are a lot of other things going on that nobody talks about. Can you speak to that? Totally. I mean, today, you know, was the announcement of the Nobel laureate around neurology. These are scientists, one out of Stanford, that were using light ontogenetics to be able to switch on and off neurons, which might be able to be useful in diseases of the brain. And that translates into stock value as well. You look at some of the recent successes.
33:22AbbVie, about a year ago, bought Cerevel. They just got approval on Jubmo. That product is being used now in Parkinson's. You look at J &J had a nice run. They acquired an early 2025 intercellular therapeutics to add to the schizophrenia pipeline. So, you know, these are these are products that are decades in the making. But if you look at the next generation of products, they're going to benefit from breakthroughs like we're seeing at the academic level. I mean, we see a portfolio of companies that are just birming with opportunities, new modalities. You look at what Elon Musk has been doing with Neuralink and other kind of companies that are working not only on drugs, but drugs with devices for disease of the brain.
34:06So so neuro and aging and these diseases. Guy was a little reluctant to ask himself, but how about anti-aging and the things that are going on with. No, but I'm actually being serious as it relates to that also as an area that has been wildly popular. Some of it really gets into more of, you know, peptides and vitamins and things that are less regulated. But truly talk about that as an opportunity set for you. It is an opportunity. Longevity, you know, broadly is an interesting investor universe as well. You look at the traditional biotech mafia that's investing primarily in very plain vanilla biotherapeutics, which is a recipe for success oftentimes.
34:48But longevity investors tend to be investors that are interested in wellness, in health, that are much broader based and oftentimes are willing to kind of underwrite AI risk in the longevity space. So it's a kind of different character that's making investments in longevity. And I think for us, we get very excited about that. Is it because it's less regulated? I mean, in other words, like there's still such an I don't know, it just seems like there's a lot of space out there where there is no FDA. Right. I think there's a greater appreciation by the investing universe as it applies to themselves.
35:21So that hits home, and that means that they want to move the needle in that regard. The science is catching up. So things where you're looking at antipsychotics, using marijuana-based approaches and psilocybin, those are becoming more mainstream because they're getting more scientifically validated and turned into drugs in a more conventional route. So I think big opportunity in anything in that space. So let me ask you one, a little painful one for me and possibly for you, too, because I think you've liked in the past, which is Nova, which just absolutely cannot get a bid no matter how much they sell of anything.
36:02What are your thoughts here? You have a good memory. I didn't think you're going to bring it up. But, yes, I think we're all in good company. I just had that pain with me every day in bidang, which we don't need to get into that. I think we spoke before the investor day when the big reveal was a brand change, and that was disappointing. I think if I look broadly at the space, move beyond Novo, I think looking over the longer term, I still believe that Novo has value. But it's a very impatient marketplace. You're impatient. I'm impatient. Lilly is just crushing it, right? So everything that Novo does to try to catch up, Lilly's got, you know, 10 times the weight in answers in the way that they go look at acquisitions and product development.
36:41You got Viking Therapeutics coming into the mix, good results with their drug. One of the recent IPOs, Kylara, led by Ron Renaud, who did the sale of Cerevelde-Avi a couple years ago, a serial successful CEO. Kylara was one of the biggest IPO events in history in the last couple of months. They licensed in products from Hangrui in China, and that's why I see 30 % of deals that are happening in licensing right now in pharma are coming from China. So watch for them to grow really aggressively in the next few years. I can't placate your concerns around NOVA in the near term, but I would just say hold for a long time and likely you'll be rewarded.
37:22Tim Seymour: Should these companies be worried that Congress will close off the Chinese pipeline, the access to some of these deals because of fears of national security? It's very politicized, as you're well aware. I think, you know, we tend to look closer to home. And, you know, I think that it's important for innovation to happen anywhere. We want to make sure from a matter of national security that we are always controlling our own destiny. If you look at some of the stats and dig deeply into the realities, from 2015 to current day, China represented about 8 % in 2015 of pharma drug development. It's gone to about 32 % today.
38:00U.S. was at about 48 % of share. It's down to about 37%. NIH is moving too slow to fund really good investments. That's also driving maybe the more trickier early-stage venture markets. FDA has not been a very transparent institution. It needs to move faster. And then even immigration. All these scientists that used to come to the U.S. to study and then apply their tools in the U.S. are all kind of going home. And so I think the U.S. needs to do a better job of creating the environment to compete. And I think that's really what will help at the national security level as well. Not so much try to control markets.
38:39Tim Seymour: Right. We have a pipeline problem. Yep. John, great to see you. Thank you. Likewise. John Flavin. You feel even worse about Novo now, right? What? I mean, you feel much worse now. I've felt worse about it for a long, long time now already. But I do think if I ever do sell it, then that will be the moment. to buy it. For sure. You'll feel worse if you sell it, I think. I don't think you can sell it.
39:04Dan Nathan: There's a bidang again. Bye, John. John's leaving.
39:09Tim Seymour: Well, I did take a bite.
39:10Dan Nathan: Well, real quick, you know, Tim mentioned he made fun of me and he should. Longevity. I mean, I get it. I'm not long for this world.
39:17Tim Seymour: No, no, but you've lived a long, I mean, we should live a full life.
39:21Dan Nathan: But, you know, along with Steven Tyler, Alan Patrikov and Abby Levy, who have a longevity tech company called primetime partners. We should get them on. Steven Tyler? No, not Steven Tyler. I said along with Steven Tyler, who we mentioned earlier. Yeah, I did not. Maybe you're the one. I need some. I need some neuro. Prevagen or something.
39:41Tim Seymour: Anyway, coming up, opportunities abroad, markets around the world taking a leg higher. Today, what our global ambassador sees in store for the international trade when Fast Money returns.
39:57Tim Seymour: Welcome back to Fast Money, The Brazil ETF hitting its highest level since February of 2020 after jumping more than 12 percent today. The gain coming after right wing Brazil Senator Flavio Bolsonaro, the son of former President Jair Bolsonaro, fared better than expected in first round elections over the weekend. He is considered more market friendly than incumbent President Lula, who he will face in a runoff later on this month. Big rally. And the question is, is there more to come at this point? I think there is. And I always going to be cautious around politics and certainly Latin America and Brazil especially are famous.
40:31But and this this is far from over. But there's a runoff. And in the prediction markets, if we think that they're doing a good job these days, are saying 80 percent. I think what it does translate into is a stronger currency, a stronger at least credit profile of the country. And therefore, both interest rate sensitives and things that are more exposed to. And again, so some of the banks we've talked about, Banco Itaú on this desk. I'm long that in iDevo. But I mean, there are places to get great Brazilian exposure across sectors that you would want to own. And maybe you grab some Brazil now, too.
41:04Latin America as a whole is moving to the right. And that's pretty good.
41:09Dan Nathan: Itaú, 8 % of the ETF. I did a good job. You say Portuguese, that's why. To the vein, to the bone. 34 % banks, another 18 % energy, 14 % materials. At a valuation that's cheap to a lot of its peers, I think, based on probably some of the unrest. Yeah, I mean, I think we've been steadfast in our love. This is probably one of the single biggest one-day moves we've seen, but it doesn't mean there's not more left in the tank. Was this in your claw? Excuse me? Claw? I'm just kidding. No, I had a clam. But how would you get Brazil in your clam? I could get it in there for you. We should probably leave this alone.
41:43Dan Nathan: Another show. Yeah. All right. It's like to see it try. Coming up.
41:48Tim Seymour: Coming up. Heating up the prediction markets, we're taking a look at some of the more interesting and even out-of-this-world contracts gaining some steam. More Fast Money in two.
41:57Dan Nathan: There she is.
42:03Tim Seymour: Welcome back to Fast Money from U.S. economic risks to one literally out-of-this-world contract. We're trading the odds of some of the biggest and most unusual bets in the prediction markets. CNBC's Contessa Brewer's got the details. I mean, basically anything that you want, you can find it on CalSheik. Odds of a recession next year, for instance, steadily falling since June's high of a little bit more than 50 percent. We can show you that. Currently, traders are pricing in a 21 percent chance of recession next year. Two back-to-back quarters of negative real GDP growth. $100 on yes would land you$451 if there is a recession next year.
42:40Tim Seymour: So how high will Bitcoin get in October? It stands at 85 ,000 right now and change. Cal sheet traders are pricing in an 82 percent chance that it hits 87.5, but only a 39 percent chance that it surpasses 92.5 this month. Not a lot of wiggle room there. Which team will be WNBA champs? The Atlanta Dream? Liberty, of course. That's wrong. Well, you can go put your money on that if you want to. But here's what we're seeing. Atlanta Dream narrowly in front of Golden State Valkyries. They kind of are swapping back and forth. Valkyries, you know.
43:16Dan Nathan: It was a song, a very famous song about the Valkyries, Tim. Flying, are they flying? Back to contestants.
43:22Tim Seymour: By the way, the semifinals continue Wednesday. We'll see if Tim is right. New York faces Atlanta. Las Vegas squaring off against Golden State. And finally, this one is far out, man. Nearly$40 million in cumulative trading volume on the question, will the U.S. confirm that aliens exist? I'd like to point out the pop in probabilities in May. Intraday, it went up to 57 percent. The closing that date was 37 percent. But at one point, 57 percent probability that the United States government would confirm the existence of aliens by January 20th, 2029. Official confirmation counts from any U.S. cabinet secretary, joint chiefs, U.S.
44:05Tim Seymour: agency head. That's a lot of people who can say, yes, there are airlines. And, of course, Trump put together a council this summer to try and explore the reality of it. I saw disclosure day and now I'm, you know, Steven Spielberg got me. Do you know, not that you, you know, traffic in this world, but do you know what happened on that day when when the odds got pushed up so high? Was there something like the announcement of that force that looked into? I mean, whenever we see those big pops, then you start looking for who put the money down and what do they know that we don't know. Now, it has fallen since then.
44:39Tim Seymour: It's back down to somewhere in the neighborhood of 20 % chance that we're going to get confirmation that aliens exist. How could they not, though, really? How could they not? How are we defining aliens? Yes, that's my question. What is an alien? Aliens are a monster right now. Extraterrestrial life. But let's say you find some insect from another planet. That counts. Okay. A tardigrade. What? The little bears, the little water bears. They can survive in any climate.
45:09Dan Nathan: No, I'm talking about a dude that walks amongst us, like me, for example. There's a very good chance that I'm an alien. Now, would I admit it if I were? It's hard to tell.
45:19Tim Seymour: Well, that wouldn't fulfill the contract. We need to hear it from, like, an agency that Guy Domi's an alien.
45:23Dan Nathan: They clearly walk amongst us. So I would be betting big on that.
45:28Tim Seymour: I mean, the Health and Human Services secretary counts as a cabinet secretary. Right. You could hear it. Anybody can say it. That's true. That's true. Contessa, thank you. Contessa Brewer. Up next, Final Trades.
45:51Tim Seymour: Time for the final trade. Let's go around the horn. Julie Beal. I like health equity. It gives you the exposure to rates, and, you know, HSAs are probably here for a while. Timbo. Guy, October 15th, right across the street at the Hard Rock Cafe. What are we doing? We're going to co-host a charity. A leg to stand on. Go check it out. You can still get tickets. In the meantime, EEM. Chairwoman. Yes, so as we're heading into earnings next week, first of all, I love that. Actual things to look at, to value things. Banks, next week. I like Citigroup going in.
46:24Dan Nathan: And you get to see Tim behind the drumming. No, I'm just singing. You're just drumming. I'm going front man. Wow. That's worth the price. Are you drumming? I'm not drumming that night. Z scale or Melissa.
46:36Tim Seymour: Thanks for watching Fast Mad Money starts right now.
47:19Dan Nathan: We'll see you next time. looking closely at how every detail could make your experience behind the wheel more rewarding. Every lesson learned and every idea refined becomes part of what comes next, and it lives inside every MDX, ADX, and Integra. That's precision crafted performance. That's Acura.
The greenback showing strength, as the dollar index hits its highest level since April 2025. How the climb in the currency, alongside rates, will impact equities… and where Citi’s JP Coviello is putting money to work. Plus, Wells gets upgraded ahead of earnings season, Chipotle’s rough run continues, and the outlook for the pharma sector;
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.